HKSE:00911 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:00911 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Qianhai Health Holdings's revenue for the six months ended in Dec. 2023 was HK$621.4 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$961.3 Mil. Qianhai Health Holdings's Revenue per Share for the six months ended in Dec. 2023 was HK$3.67. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$5.67.
Warning Sign:
Qianhai Health Holdings Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Qianhai Health Holdings was -51.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 54.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 11 years, Qianhai Health Holdings's highest 3-Year average Revenue per Share Growth Rate was 57.10% per year. The lowest was -69.80% per year. And the median was 9.75% per year.
The historical data trend for Qianhai Health Holdings's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qianhai Health Holdings Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Revenue | Get a 7-Day Free Trial | 587.81 | 760.72 | 283.40 | 1,961.70 | 961.29 |
Qianhai Health Holdings Semi-Annual Data | ||||||||||||||||||||
Jun14 | Dec14 | Jun15 | Dec15 | Jun16 | Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | |
Revenue | Get a 7-Day Free Trial | 87.68 | 1,201.28 | 760.43 | 339.90 | 621.39 |
For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's Revenue distribution charts can be found below:
* The bar in red indicates where Qianhai Health Holdings's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$961.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qianhai Health Holdings (HKSE:00911) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Thank you for viewing the detailed overview of Qianhai Health Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Huang Guanchao | 2101 Beneficial owner | |
Shinewing Sas (nominee Services) No. 3 Limited | 2501 Other | |
Hou Chung Man | 2501 Other | |
Tang Chung Wah | 2501 Other | |
Sparkling Rock Limited | 2201 Interest of corporation controlled by you | |
Chong Siew Hoong | 2202 Interest of your spouse | |
Lim Tzea | 2101 Beneficial owner | |
Explorer Rosy Limited | ||
Great Prosperous Limited | ||
Noble Stand Global Limited | ||
Thousands Beauties Limited | ||
Yunnan Energy Investment (h K) Co. Limited | 2106 Person having a security interest in shares | |
Yunnan International Holding Group Limited | 2106 Person having a security interest in shares | |
Yunnan International Supply Chain Limited | 2106 Person having a security interest in shares | |
Yunnan Provincial Energy Investment Group Co., Ltd | 2106 Person having a security interest in shares |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.